Ibrutinib More Effective Than Stem-Cell Transplant in Patients With Form of Chronic Leukemia – AJMC.com Managed Markets Network
|
Ibrutinib More Effective Than Stem–Cell Transplant in Patients With Form of Chronic Leukemia
AJMC.com Managed Markets Network An analysis presented at the 59th Annual Meeting of the American Society of Hematology showed that against a 3-year horizon, ibrutinib suceeds in overall survival (OS) and progression free suvrvival (PFS) over hematopoetic stem–cell transplantation … |
